PYRITINOL USAGE IN PEDIATRIC NEUROLOGY
https://doi.org/10.15690/vsp.v12i4.728
Abstract
Treatment of developmental disorders, correction of learning disabilities and behavioral problems in children should be prompt, complex and include pharmacotherapy with nootropic agents. The results of recent studies shown in this review proved effectiveness of pharmacotherapy with pyritinol in children with perinatal injury of central nervous system and its consequences, psychomotor and speech development delay, dyslexia, attention deficit/hyperactivity disorder, cognitive disorders and learning disabilities (including manifestations of epilepsy, chronic tic disorders and Tourette syndrome). Due to its ability to optimize metabolic processes in central nervous system, pyritinol is used in treatment of vegetative dysfunction in children and adolescents, especially associated with asthenical manifestations, as well as in complex therapy of exertion headache and migraine. The drug is effective in treatment of cognitive disorders in children and adolescents with epilepsy, pyritinol was administered without changing of the basic anticonvulsive therapy and no deterioration (increase of severity of seizures or intensity of epileptiform activity on electroencephalogramms) was observed. Significant nootropic effect of pyritinol, including neurometabolic, neuroprotective, neurodynamic and other mechanisms, in association with safety and rare side effects of this drug determines its wide usage in pediatric neurology.
About the Authors
N. N. Zavadenko
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Zavadenko Nikolai Nikolaevich, PhD, professor, Head of the Department of Neurology, Neurosurgery and Clinical Genetics of Pediatric Faculty
Russian Federation
Zavadenko Nikolai Nikolaevich, PhD, professor, Head of the Department of Neurology, Neurosurgery and Clinical Genetics of Pediatric Faculty
Yu. E. Nesterovskii
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
E. V. Kozlova
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
References
1. Nootropy v kognitivnoi nevrologii detskogo vozrasta. Pos. dlya vrachei [Nootropics in Cognitive Neurology Research in Children. Guideline for Doctors]. Moscow, NTsZD RAMN, 2010. 54 p.
2. Voronina T. A., Seredenin S. B. Eksperimental’naya i klinicheskaya farmakologiya — Experimental and Clinical Pharmacology. 1998; 61 (4): 3–9.
3. Ivanets N. N., Igonin A. L., Savchenko L. M. etc. Entsefabol: aspekty klinicheskogo primeneniya. Sb. nauch. statei [Encephabol: Aspects of Clinical Application. Collection of Scientific Articles]. Moscow, Sovero-press, 2001. 80 p.
4. Benesova O., Krejci I., Pavlik A. Nootropic Drugs. Prague, Avicenum, 1991. 202 p.
5. Yanovskaya N. V., Evtushenko O. S., Lisovskii E. V. etc. Mezhdunarodnii nevrologicheskii zhurnal — International Neurological Journal. 2006; 2 (6): 23–25.
6. Zavadenko N. N., Kozlova E. V., Koltunov I. E. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova — Journal of neurology and psychiatry of S. S. Korasokov. 2012; 112 (7/2): 90–95.
7. Chutko L. S., Surushkina S.Yu., Yakovenko E. A., Bykova Yu. L., Nikishena I. S. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova — Journal of neurology and psychiatry of S. S. Korasokov. 2011; 111 (9/2): 37–40.
8. Mal'mberg S. A., Ogurtsova E. A. Consilium medicum (Pediatriya) — Consilium medicum (Pediatrics). 2009; 1: 68–72.
9. Zavadenko N. N., Suvorinova N.Yu., Rumyantseva M. V. Consilium medicum (Pediatriya) — Consilium medicum (Pediatrics). 2006; 2: 47–52.
10. Andreenko N. V., Maspova O. I., Perederni E. E. Effektivnost' Entsefabola v korrektsii kognitivnykh narushenii u mal'chikov shkol'nogo vozrasta. Entsefabol: aspekty klinicheskogo primeneniya [Effectiveness of Application of Encephabol for Remodeling of Cognitive Deteriorationin Boys of School Age. Encephabol: Aspects of Clinical Application]. Moscow, Sovero-press, 2001. pp. 73–78.
11. Zykov V. P., Begasheva O. I. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova — Journal of neurology and psychiatry of S. S. Korasokov. 2003; 103 (11): 10–14.
12. Lobov M. A., Grin'ko A. N., Panteleeva M. V., Knyazev A. B. Neiroprotektivnye preparaty v korrektsii gemodinamicheskikh i neirofiziologicheskikh parametrov pri obshchem obezbolivanii u detei. Sovr. nauch. napravl. v nevrol. (Yubileinyi al'manakh nauch. tr.) [Neuroprotective Medicine for Improvement of Hemodynamic Parameters and Neurophysiological Measures in the Procedure of General Anesthesia in Children. Current Scientific Research in Neurology. Anniversary Almanac of Scientific Proceedings]. Moscow, 2003. pp. 148–149.
13. Nesterovskii Yu. E., Petrukhin A. S., Goryunova A. V. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova — Journal of neurology and psychiatry of S. S. Korasokov. 2007; 107 (1): 11–15. 14. Korovina N. A., Tvorogova T. M. Gavryushova L. P., Zakharova I. N. RMZh — Russian Medical Journal. 2006; 19: 1356–1360.
14. Nesterovskii Yu. E., Zavadenko N. N. Effektivnaya farmakoterapiya — Effective Pharmocotherapy. 2012; 3: 34–40.
15. Maslova N., Egorova N., Sinel'shchikova A. Vrach — Doctor. 2010; 1: 35–37.
16. Zenkov L. R. Lechashchii vrach — Practicing Doctor. 2010; 9: 50–54.
17. Zenkov L. R., Zenkova A. L. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova — Journal of neurology and psychiatry of S. S. Korasokov. 2011; 111 (5/2): 74–77.
18. Pilipovich A. A. Effektivnaya farmakoterapiya — Effective Pharmocotherapy. 2011; 1: 65–71.
Review
For citations:
Zavadenko N.N., Nesterovskii Yu.E., Kozlova E.V. PYRITINOL USAGE IN PEDIATRIC NEUROLOGY. Current Pediatrics. 2013;12(4):32-37. (In Russ.) https://doi.org/10.15690/vsp.v12i4.728
Views:
1260
Email this article 
